It has also been demonstrated that patients with IPEX syndrome who have missense mutations and deletions in splicing sites do not have Treg CD4+CD25+Foxp3+ lymphocytes and have a more severe form of the disease. This evidence concerns the gene IL2RA and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.